Dédicaces - Faculté de Médecine et de Pharmacie de Fès

63- Bourhis J, Armand JP, Pignon JP
Update of MACH-NC Meta-Analysis of Chemotherapy in Head and Neck Cancer
database focused on concomitant chemoradiotherapy.
Proc Am Soc Clin Oncol 2004;22
64- Bernier J, Domenge C, Ozshain M, Matuszewska K, Lefebvre JL, Greiner RH, et al
.
Postoperative irradiation with or without concomitant chemotherapy for locally
advanced head and neck cancer.
N Engl J Med 2004;350:1945–52.
65- Vermorken JB, Remenar E, van Hepen C, Germa Lluch J, Stewart S, Gorlia T, et al.
Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as
neoadjuvant chemotherapy for nonresectable locally advanced squamous cell
carcinoma of the head and neck (LASCCHN): a phase III trial of the EORTC Head and
Neck Cancer Group (EORTC #24971).
Proc Am Soc Clin Oncol 2004;22
66- Department of Veterans Affairs Laryngeal Cancer Study Group.
Induction chemotherapy plus radiation compared with surgery plus radiation in
patients with advanced laryngeal cancer.
N Engl J Med 1991;324:1685–90.
67- Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick T, Collette L, Shamoud T.
Larynx preservation in piriform sinus cancer: preliminary results of a European
Organization for Research and Treatment of Cancer phase III trial. EORTC Head and
Neck Cancer Cooperative Group.
J Natl CancerInst 1996;88:890–9.
68- Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, et
al.
Randomized trial of induction chemotherapy in larynx carcinoma.
Oral Oncol 1998; 34:224–8.
69- Lefebvre JL, Wolf G, Luboinski B.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (2) Larynx
preservation using neoadjuvant chemotherapy in laryngeal and hypopharyngeal
carcinoma.
Proc Am Soc Clin Oncol 1998;17
146